The largest database of trusted experimental protocols

Hitrap sp sepharose column

Manufactured by GE Healthcare
Sourced in Sweden

The HiTrap SP-Sepharose column is a pre-packed ion exchange chromatography column used for the purification and separation of biomolecules. It consists of SP-Sepharose, a strong cation exchange resin, packed into a ready-to-use column format. The column is designed for fast and easy purification of proteins, peptides, and other charged biomolecules.

Automatically generated - may contain errors

5 protocols using hitrap sp sepharose column

1

Purification of TFIID Subunits

Check if the same lab product or an alternative is used in the 5 most similar protocols
MBP–TAF8-fusion proteins were produced in E. coli Rosetta (DE3) cells (Novagen) and purified by metal affinity chromatography using TALON resin (Clontech) followed by size-exclusion chromatography on a Superdex 200 16/60 column (GE Healthcare; detailed in Supplementary Methods). Importin α1 constructs (residues 60–529 or residues 71–497) were produced and purified as described54 (link), except that E. coli Rosetta (DE3) cells (Novagen) were used. Production and purification of core–TFIID and 7TAF complexes was performed as described12 (link).
Proteins TAF2, MBP–TAF2, mCherry-TAF2 and TAF8–10 complex were produced using the MultiBac system53 (link). Expressed protein was captured via TALON resin (Clontech) from the cell lysate in batch. Proteins were further purified by ion exchange chromatography using a 5-ml SP-Sepharose HiTrap column (GE Healthcare) followed by gel filtration using Superdex200 10/300 or Superose6 10/300 columns (GE Healthcare; Supplementary Methods). Proteins were flash frozen in liquid nitrogen and stored at −80 °C in aliquots.
+ Open protocol
+ Expand
2

Sortase-Mediated Bioconjugation of MMAE-Affibody and MMAE-FGF2 Constructs

Check if the same lab product or an alternative is used in the 5 most similar protocols
The conjugated proteins were diluted in 25 mM HEPES, 154 mM NaCl, 5 mM CaCl2, 2 mM TCEP pH 7.6 to final concentration of 35 uM, then G3PEG12-Biotin was added to a final concentration of 100 µM. Sortase A was then added to a final concentration of 2 μM and the mixture was incubated for 3 h for MMAE-FGF2V and 12 h for MMAE-AfiibodyHER2 at 15 °C. Biotinylated MMAE-AffibodyHER2 (MMAE-AffibodyHER2-Biot) was purified by ion exchange chromatography using a SP Sepharose HiTrap column (GE Healthcare). Elution was performed in 25 mM HEPES, 0.5 M NaCl, 200 mM urea, 1 mM TCEP, CaCl2 2 mM, pH 7.6. Biotinylated MMAE-FGF2V (MMAE-FGF2V-Biot) was purified by affinity chromatography with a Heparin HiTrap column (GE Healthcare). Protein elution was performed using 25 mM HEPES, 2 M NaCl, 25 mM Na2SO4, 5% Glycerol pH 7.4.
+ Open protocol
+ Expand
3

Recombinant Archaeal Protein Purification

Check if the same lab product or an alternative is used in the 5 most similar protocols
The P. abyssi recombinant proteins were expressed from three derived pET15b vectors: two of them had L7Ae or aFib genes cloned separately (Bortolin et al. 2003 (link)), whereas the third had Nop5 and aFib genes cloned together as a natural tandem, resulting in amino-terminally His-tagged L7Ae, aFib, and Nop5, respectively. The aFib D150A mutation was introduced into the aFib–Nop5 coexpression vector by the “megaprimer” PCR method (Sarkar and Sommer, 1990 (link)). The proteins were expressed in E. coli BL21 (DE3) RIL (Stratagene) cells after induction with 1 mM isopropyl-β-D-thiogalactoside. Following sonication, E. coli proteins were precipitated by thermodenaturation at 65°C for 15 min. Nucleic acids from aFib–Nop5 preparation were removed by precipitation with 2 M LiCl (1 h on ice), and from L7Ae preparation by addition of 0.15% polyethylenimine. His6-tagged proteins were purified by Ni2+ chelate chromatography on a HiTrap IMAC HP column (GE Healthcare). The heterodimer aFib–Nop5 was obtained by copurification using His6-tagged Nop5. After purification, the His6-tags were removed by thrombin (Amersham) treatment. L7Ae protein was further purified on a HiTrap SP-sepharose column (GE Healthcare).
+ Open protocol
+ Expand
4

Purification and Characterization of EgKI-1

Check if the same lab product or an alternative is used in the 5 most similar protocols
The cultured supernatant (200 ml) was then collected by centrifugation at 12,000 rcf for 30 min at 4°C and stored at -80 0C until required. The supernatant was thawed, dialyzed into 50 mM MES buffer (pH 6) and filtered through a 0.45 μm filter before being loaded on to a Hi-trap SP sepharose column (GE Healthcare Life Sciences) pre-equilibrated with 50 mM MES buffer (pH 6) [18 (link)]. Unbound material was removed by washing with equilibration buffer and protein was eluted using a linear gradient of 0–1 M NaCl over 40 ml, with EgKI-1 eluting between 0.4 and 0.6 M NaCl. Purification was monitored by analysis on SDS-PAGE gels and protease inhibitory activity in fractions containing EgKI-1. Purified EgKI-1 was then dialyzed into 50 mM Tris 120 mM NaCl (pH 7) buffer and quantified using the Bradford protein assay [19 (link)]. A sample of the EgKI-1 protein was visualized on 15% SDS-PAGE to verify its purity and the EgKI-1 gel band was subjected to in-gel trypsin digestion and nano high performance liquid chromatography coupled to mass spectrometry (nano LC-MS) [20 (link)].
+ Open protocol
+ Expand
5

Purification and Characterization of Brazzein

Check if the same lab product or an alternative is used in the 5 most similar protocols
The yeast supernatant containing secreted brazzein was clarified by centrifugation at 21,600× g for 20 min at 4 °C and by filtration (0.22 µm, Startorius, Göttingen, Germany). Brazzein supernatant was dialyzed in three successive steps against 10 L of 50 mM ammonium acetate, pH 4.0, at 4 °C for 2 days and then loaded onto a HiTrap SP-Sepharose column (5 mL, GE Healthcare Biosciences, Uppsala, Sweden) previously equilibrated with 50 mM ammonium acetate buffer, pH 4.0. The column was washed with 50 mM ammonium acetate, pH 4.0, and elution was performed using an increasing NaCl gradient (from 0 to 1 M). A desalting dialysis was operated against 1 L of 20 mM phosphate potassium adjusted to pH 4.0 using phosphoric acid at 4 °C for 1 day. Under magnetic stirring, the pH level of purified brazzein was raised to 7.5 with 1 M potassium phosphate, pH 7.5. Then, under the same conditions, a second dialysis was performed against 50 mM potassium phosphate pH 7.5. Fractions containing brazzein were concentrated using a Vivaspin concentrator (3 kDa molecular mass cutoff), pooled, and stored at −20 °C. The brazzein concentration was determined spectrophotometrically using an extinction coefficient at 280 nm of 8940 M−1.cm−1.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!